According to Eagle Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is โฌ0.22 Billion. In 2022 the company made a revenue of โฌ0.29 Billion an increase over the revenue in the year 2021 that were of โฌ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | โฌ0.24 B | -17.26% |
2022 | โฌ0.29 B | 94.86% |
2021 | โฌ0.15 B | -0.79% |
2020 | โฌ0.15 B | -12.68% |
2019 | โฌ0.17 B | -6.22% |
2018 | โฌ0.18 B | -5.48% |
2017 | โฌ0.19 B | 9.51% |
2016 | โฌ0.18 B | 197.41% |
2015 | โฌ60.57 M | 283.53% |
2014 | โฌ15.79 M | 23.31% |
2013 | โฌ12.8 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | โฌ77.32 B | 34,584.78% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | โฌ35.13 B | 15,658.66% | ๐ฌ๐ง UK |
![]() Novartis NVS | โฌ46.06 B | 20,564.65% | ๐จ๐ญ Switzerland |
![]() Teva Pharmaceutical Industries TEVA | โฌ14.38 B | 6,351.15% | ๐ฎ๐ฑ Israel |
![]() Amgen AMGN | โฌ29.53 B | 13,150.19% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | โฌ42.41 B | 18,926.60% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | โฌ41.23 B | 18,395.75% | ๐บ๐ธ USA |